✦ LIBER ✦

Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States

✍ Scribed by Casciano, Roman; Chulikavit, Maruit; Perrin, Allison; Liu, Zhimei; Wang, Xufang; Garrison, Louis P.

Book ID: 118057778
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 425 KB
Volume: 15
Category: Article
ISSN: 1369-6998
DOI: 10.3111/13696998.2012.720319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN93 Treatment of Well-Differentiated P

PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression: Cost-Utility and Cost-Effectiveness Analysis

✍ J. Walczak; M. Garbacka; J. Zawieja; P. Prząda-Machno; J. Kroc 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness of Treating Chronic A

Cost-effectiveness of Treating Chronic Anemia with Epoetin Alfa among Hemodialysis Patients in the United States

✍ Peter Quon; Matthew Gitlin; John J. Isitt; Sumit Mohan; William M. McClellan; Ji 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 495 KB

Therapy conversion to insulin detemir am

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: A modeling study of cost-effectiveness in the United States

✍ William J. Valentine; K. M. Erny-Albrecht; J. A. Ray; S. Roze; D. Cobden; A. J. 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB